151 related articles for article (PubMed ID: 36539582)
1. ASO Author Reflections: Risk Stratification of Sentinel Node Metastases in Stage III Melanoma Patients in the Era of Adjuvant Systemic Therapy.
Hussain Z; Moncrieff M
Ann Surg Oncol; 2023 Mar; 30(3):1820-1821. PubMed ID: 36539582
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: The Clinical Relevance of Sentinel Nodes in Minor Lymph Node Fields Such as the Triangular Intermuscular Space in Patients with Melanoma.
Schoenfeldt T; Chakera AH; Nieweg OE; Thompson JF
Ann Surg Oncol; 2023 Sep; 30(9):5770-5771. PubMed ID: 37133568
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Role of Sentinel Lymph Node Biopsy in T1b Melanoma.
Hu Y; Brady MS
Ann Surg Oncol; 2020 Dec; 27(13):5257-5258. PubMed ID: 32529270
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Comparison of Indocyanine Green with Blue Dye in Sentinel Lymph Node Biopsy for Cutaneous Melanoma.
Fadel MG; Smith MJ
Ann Surg Oncol; 2023 Jul; 30(7):4341-4342. PubMed ID: 37014554
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy.
Farrow NE; Beasley GM
Ann Surg Oncol; 2020 Dec; 27(13):5126-5127. PubMed ID: 32409964
[No Abstract] [Full Text] [Related]
6. [Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices].
Orion C; Dinulescu M; Dalac-Rat S; Giacchero D; Jouary T; Lebbé C; Leccia MT; Maubec E; Meyer N; Mortier L; Dupuy A;
Ann Dermatol Venereol; 2020 Jan; 147(1):9-17. PubMed ID: 31761496
[TBL] [Abstract][Full Text] [Related]
7. ASO Author Reflections: The Impacts of a Negative Sentinel Lymph Node on Quality of Life.
Banting S; Gyorki DE
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):651-652. PubMed ID: 31228135
[No Abstract] [Full Text] [Related]
8. Completion Node Dissection for Sentinel Node-Positive Melanoma: Can a Systematic Review Bring One Discussion to a Close While Leaving the Broader Conversation Still Open?
Berman RS; Gershenwald JE
Ann Surg Oncol; 2019 Apr; 26(4):921-923. PubMed ID: 30737667
[No Abstract] [Full Text] [Related]
9. Sentinel Lymph Node Biopsy for Melanoma: Buggy Whip or Roller Bearing?
Karakousis GC; Faries MB
Ann Surg Oncol; 2020 Aug; 27(8):2586-2588. PubMed ID: 32519145
[No Abstract] [Full Text] [Related]
10. Surgical approach to patients with low-burden stage III melanoma: Is it time to consider conservative surgery?
Moreno-Ramírez D; Vieira R; Kaufmann R
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):498-500. PubMed ID: 31767498
[No Abstract] [Full Text] [Related]
11. Counterpoint: Surgical Management of Lymph Node Basin in Sentinel Lymph Node-Positive Melanoma.
Ross MI
Oncology (Williston Park); 2016 Oct; 30(10):891, 893-5. PubMed ID: 27753055
[No Abstract] [Full Text] [Related]
12. Point: Surgical Management of Lymph Node Basin in Sentinel Lymph Node-Positive Melanoma.
Sarnaik AA; Zager JS; Sondak VK
Oncology (Williston Park); 2016 Oct; 30(10):891-2, 895. PubMed ID: 27753054
[No Abstract] [Full Text] [Related]
13. Sentinel Lymph Node Biopsy: Indications and Technique.
Crystal J; Faries MB
Surg Oncol Clin N Am; 2020 Jul; 29(3):401-414. PubMed ID: 32482316
[TBL] [Abstract][Full Text] [Related]
14. Sentinel Lymph Node in Thin and Thick Melanoma.
Roncati L; Piscioli F; Pusiol T
Klin Onkol; 2016; 29(5):393-394. PubMed ID: 27739319
[No Abstract] [Full Text] [Related]
15. In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up?
Thompson JF
Ann Surg Oncol; 2021 Nov; 28(12):6915-6917. PubMed ID: 34365560
[No Abstract] [Full Text] [Related]
16. A commentary on "Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study" - correspondence.
Saravanan M; Arockiaraj J; Belete MA
Int J Surg; 2024 Mar; 110(3):1862-1863. PubMed ID: 38116653
[No Abstract] [Full Text] [Related]
17. Challenges in sentinel node pathology in the era of adjuvant treatment.
Franke V; Madu MF; Bierman C; Klop WMC; van Houdt WJ; Wouters MWJM; van de Wiel BA; van Akkooi ACJ
J Surg Oncol; 2020 Oct; 122(5):964-972. PubMed ID: 32602119
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
19. Underuse of sentinel lymph node biopsy for early-stage melanoma.
Rajeh A; Wan G; Roster K; Rashdan H; Seo J; Nguyen N; Collier MR; Leung BW; Semenov YR
J Am Acad Dermatol; 2023 Oct; 89(4):803-806. PubMed ID: 37244413
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Recurrence in Sentinel Node-Positive Node Fields in Melanoma Patients Undergoing Surveillance Is More Common outside the Node Field.
Gjorup CA; van Akkooi ACJ
Ann Surg Oncol; 2024 Mar; 31(3):1880-1881. PubMed ID: 38044350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
